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Background. If detected in time, delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH) may be treated
by balloon angioplasty or chemical vasospasmolysis in order to enhance cerebral blood flow (CBF) and protect the brain from
ischemic damage. This study was conceived to compare the diagnostic accuracy of detailed neurological examination, Transcranial
Doppler Sonography (TCD), and Perfusion-CT (PCT) to detect angiographic vasospasm. Methods. The sensitivity, specificity,
positive and negative predictive values of delayed ischemic neurological deterioration (DIND), pathological findings on PCT-
maps, and accelerations of the mean flow velocity (MVF) were calculated. Results. The accuracy of DIND to predict angiographic
vasospasm was 0.88. An acceleration of MFV in TCD (>140 cm/s) had an accuracy of 0.64, positive PCT-findings of 0.69 with a
higher sensitivity, and negative predictive value than TCD. Interpretation. Neurological assessment at close intervals is the most
sensitive and specific parameter for cerebral vasospasm. PCT has a higher accuracy, sensitivity and negative predictive value than
TCD. If detailed neurological evaluation is possible, it should be the leading parameter in themanagement and treatment decisions.
If patients are not amenable to detailed neurological examination, PCT at regular intervals is a helpful tool to diagnose secondary
vasospasm after aneurysmal SAH.
1. Introduction
Among other variables, cerebral infarction and symptomatic
vasospasm are the most important postoperative risk factors
for poor outcome after aneurysmal SAH [1] Both are con-
sequences of a decreasing and insufficient brain perfusion
that eventually causes a loss of neurological function and,
finally, structural damage of brain tissue [2]. A variety of
measures is undertaken to enhance cerebral blood flow
(CBF) in SAH-patients developing delayed cerebral vasos-
pasm (DCV). These include hyperdynamic therapy, intra-
arterial and intrathecal drug infusion, intra-aortic bal-
loon counterpulsation, and new experimental methods [3].
Endovascular treatment of DCV—balloon angioplasty and
chemical vasospasmolysis—has proven to effectively enhance
CBF and has been increasingly used for treatment of DCV
in the last years [4]. The application of these modalities or
their combination may be very helpful if treatment is started
in time. However, the routine use of repeated four-vessel
angiography is not justifiable because of high-radiation
exposure. Therefore, other monitoring tools have to indicate
upcoming vasospasm after aneurysmal SAH. If DCV is
missed or treatment started too late, cerebral infarction
might develop in spite of maximum treatment. A number
of monitoring methods are available. The use of continuous
invasive brain monitoring like bedside microdialysis or
intracerebral measurement of tissue oxygenation or regional
cerebral blood flow (rCBF) is discussed with controversy.
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The ideal monitoring is noninvasive, can be repeated any
time without extensive technical setup, has a high-diagnostic
accuracy, and gives information about the development of
DCV and the decrease of cerebral perfusion early enough to
start an adequate therapy and prevent cerebral infarction.
Neurological assessment and TCD are noninvasive proce-
dures. PCT obtained at regular intervals is only little invasive
regarding the exposure to radiation. This study was designed
to evaluate and compare these diagnostic modalities for
their prognostic value to detect angiographic vasospasm and
perform endovascular treatment.
2. Materials and Methods
The study was approved by the local ethics committee. The
data was collected in the framework of a clinical trial assess-
ing the effectiveness of magnesium treatment in aneurysmal
SAH [5]. The patients analyzed in the present study resemble
the control group of this clinical trial. In order to prevent a
possible contamination of results by a drug with vasodilatory
and neuroprotective potential, patients receiving magnesium
medication were not included in this analysis. Informed
consent was obtained from the patient or a legal guardian.
2.1. Inclusion- and Exclusion-Criteria. Patients were eligible
for inclusion if they had suffered aneurysmal SAH no longer
than 96 hours ago. Patients were not included if they were
under 18 years of age, if treatment was discontinued at the
time of hospital admission due to a poor clinical state on
admission, if there was a history of preceding aneurysmal
SAH, or if therapy was scheduled to be continued elsewhere
after obliteration of the aneurysm. Further exclusion criteria
were pregnancy, cancer, atrioventricular block, preexisting
neuromuscular disease, and renal failure. If serum creatinine
values were above 133 µmol/L (1.5mg/100mL), values were
controlled 8 hours later after fluid substitution with 1.5 liters
of Ringer’s solution. If serum creatinine had declined below
133 µmol/L, the patient was included in the study.
All patients were admitted to the neurosurgical intensive
care unit. The intervals from the presumable aneurysm
rupture until hospital admission were documented as well as
comorbidity and medication. The neurological examination
was performed according to an examination protocol which
included assessment and documentation of the Glasgow
Coma Score (GCS), deficits of awareness (person, place,
time, situation), deficits of cranial nerves, visual field deficits,
motor and sensory deficits of the upper and lower extremi-
ties, coordination deficits, and speech abnormalities.
2.2. Assessment of Study Parameters. Neurological examina-
tion: Detailed neurological examination was conducted 3
times a day (1 a.m., 9 a.m., and 5 p.m.) by the neurosurgeon
on duty on the ICU following the above mentioned neuro-
logical examination protocol. Any secondary deterioration of
the neurological state was considered abnormal. If secondary
deterioration was detected and confirmed by the senior neu-
rosurgeon on duty, blood counts and serum electrolytes were
determined and a CT-scan was obtained. Delayed Ischemic
Neurological Deficit (DIND) was defined as a secondary
neurological deterioration after exclusion of rebleeding or
intracerebral hemorrhage, hydrocephalus, seizure, or elec-
trolyte disturbance. The examiners were not involved in the
conduction and analysis of Transcranial Doppler Sonog-
raphy and Perfusion-CT.
Transcranial Doppler Sonography (TCD): The TCD
examination was conducted daily after the neurological
examination in the morning by a trained and experienced
medical technician who was blinded to the result of the
neurological examination. The mean flow velocities (MFV)
in the vessel trunks of both middle, anterior, and posterior
cerebral arteries (MCA, ACA, PCA) were determined via a
temporal window, the MFV in the basilar artery was deter-
mined via the foramen magnum. Sonographic vasospasm
was defined as a MFV >140 cm/s in the MCA, ACA and/or
PCA or a MFV of >90 cm/s in the basilar artery.
Perfusion CT: Native CT and PCT were obtained at day
3 or 4, day 6 or 7, and day 9 or 10 after admission or at any
other point if it was thought to be of diagnostic relevance.
If patients were hospitalized longer, further CT/PCT-scans
were obtained at 3-day intervals. For the determination of
irreversible brain infarction on native CT, diagnostic criteria
were applied as previously described [6]. For the native CT,
slice thickness was 5mm for the posterior fossa and 8mm
for the cerebrum (Somatom Plus 4 Volume Zoom, Siemens,
Erlangen, Germany). Slice positioning was above the orbital
roof in the supraorbitomeatal direction.
Perfusion CT was obtained as previously described [7].
In brief, two adjacent 10-mm slices were positioned at the
level of the basal ganglia with the same angulation as for
native CT. A bolus of 50mL of nonionic contrast medium
(Imeron 400, Bracco, Konstanz, Germany) was administered
by a power injector into a central venous catheter at a flow
rate of 4mL/s followed by 30 mL of saline. Four seconds
after beginning of the bolus, 40 images were collected at
each slice level at a rate of two images per second (120 kV,
110mAs, matrix 512×512). For PCT analysis a commercially
available software was used (Perfusion CT, Siemens). PCT
color maps were qualitatively assessed using a visual grading
scale [7, 8]. A positive visual assessment was noted for side-
to-side asymmetries or clear bilateral defects suggesting a
decrease in Cerebral Blood Flow (CBF), Cerebral Blood
Volume (CBV), or an increase in Time To Peak (TTP)
(Figure 1). CT and Perfusion-CT was analyzed by trained
neuroradiologists (M.P., L.S.) and a trained neurosurgeon
(C.S.) blinded to the patient data, neurological exam, and
TCD values.
2.3. Target Parameters. The target parameter was angio-
graphic vasospasm. Patients were forwarded to digital sub-
traction angiography (DSA) in case of neurological deterio-
ration which was not explained by other reasons (rebleeding,
seizure, and electrolyte disturbance), steep elevations of flow
velocities in TCD, and/or clear and newly appearing deficits
in perfusion CT. Angiographic vasospasm was defined as a
narrowing of the diameter of a vessel trunk ofmore than 30%
and a significant consecutive delay of contrast flow distal to
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Figure 1: Perfusion-CT of a 40-year-old female patient with subarachnoid hemorrhage Hunt/Hess 3 caused by rupture of a right posterior
communicating artery aneurysm. (a) Basis scan, (b) CBF map, (c) Blood Volume map, and (d) time to peak map. While the CBF map and
Blood Volume map do not show signs of a perfusion deficit, the TTP map depicts an asymmetry in the posterior MCA-territory indicating
spasm of the right terminal carotid artery and MCA.
the spastic segment. The DSA images were digitally stored,
measured, and reanalyzed by a neuroradiologist blinded to
the results of the neurological exam, TCD, and PCT. If the
criteria for vasospasm were fulfilled and the spastic segment
was accessible to a microcatheter, balloon angioplasty was
performed. If the criteria were fulfilled but the segment was
not accessible for a microcatheter, chemical spasmolysis with
papaverin or nimodipine was performed.
Diagnostic accuracy of neurological assessment, TCD,
and qualitative CTP was determined by sensitivity, speci-
ficity, and positive and negative predictive values (PPV,
NPV).
3. Results
The studies were conducted in the framework of a clinical
trial assessing the therapeutical potential of magnesium sul-
fate to protect from secondary ischemic events after SAH [5].
In this study, magnesium showed a spasmoprotective effect.
To prevent contamination of the data, only patients of the
control group of this study are presented here.
3.1. Patient Characteristics. 53 patients completed the study
protocol and were analyzed. Secondary cerebral infarctions
occurred in 27 patients. 39 territorial and 11 lacunar infarc-
tions were counted.
3.2. Neurological Assessment. 31 patients were amenable to
neurological assessment through major parts of their
hospitalization. 18 episodes of DIND were registered in 15
patients. 11 times, patients were forwarded to DSA on the
same day or on the next day. In 9 of these patients, DSA
showed significant vasospasm and all were treated by balloon
dilatation. 5 times, DSA was performed for other reasons
than DIND and was negative in all 5 cases (sensitivity for
DIND to predict angiographic vasospasm 1.00, specificity
0.33, PPV 0.69, NPV 1.00).
3.3. Transcranial Doppler Sonography (TCD). MFV in the
large intracranial vessel trunks was assessed daily by TCD in
all patients from admission until the end of the treatment.
Cerebral vasospasm in TCD was defined as MFV higher than
140 cm/s. 45 patients had MFV of more than 140 cm/s for 1
day or longer during the hospital stay.
50 angiographies for suspected vasospasm were per-
formed in 29 patients. 37 of these procedures were paralleled
by MFV over 140 cm/s in one or more intracranial vessel
trunks. 27 of these procedures revealed significant vasospasm
and were treated by balloon angioplasty or chemical vasos-
pasmolysis. 13 times, MFV was lower than 140 cm/s and
angiography was performed for other reasons (DIND, PCT).
Of these patients, 8 showed angiographic vasospasm (sen-
sitivity for accelerated flow velocity >140 cm/s to predict
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angiographic vasospasm 0.77, specificity 0.44, PPV 0.73, and
NPV 0.62).
3.4. Perfusion CT (PCT). Serial CT-scans and PCT-maps
were obtained on admission, on days 3/4, 6/7, 9/10, or any
other day when it was considered to be of diagnostic
relevance. 92 CBF- and Blood Volume maps were positive.
27 positive examinations were followed by angiography. 19
of these angiographies showed significant vasospasm and 8
were negative. In 19 cases, angiography was performed for
other reasons. 8 were negative and 12 showed significant
angiographic vasospasm requiring treatment (sensitivity for
CBF- and Blood Volume maps to predict angiographic
vasospasm 0.61, specificity 0.47, PPV 0.70, and NPV 0.37).
Except for 2 cases, CBF- and blood volume maps were posi-
tive when infarction or hemorrhage or postoperative contu-
sion was already demarcated in plain CT-scans.
97 TTP-maps were positive and were followed by angiog-
raphy 38 times. 27 of these angiograms showed significant
vasospasm and 11 were negative. In 6 patients, angiography
was performed for other reasons. 4 of these angiograms were
negative, 2 were positive (sensitivity for TTP maps to predict
vasospasm 0.93, specificity 0.27, PPV 0.71, and NPV 0.67).
3.5. Simultaneous Positive Findings in TCD and Time To
Peak. In 45 patients, both TCD-values and TTP-maps were
obtained prior to angiography. Angiography showed a
positive result in 30 cases. 23 of these patients had both MFV
higher than 140 cm/s and positive TTP maps. 14 angiogra-
phies were negative. 6 of these patients had both elevated
MFV in TCD and positive TTP maps (sensitivity for both
positive TCD- and TTP-findings at the same time to predict
angiographic vasospasm 0.74, specificity 0.57, PPV 0.79, and
NPV 0.53).
4. Discussion
This study assessed neurological examination, Transcranial
Doppler Sonography, and Perfusion CT for their ability to
predict cerebral vasospasm after aneurysmal SAH. DSA is
the gold standard in the diagnosis of cerebral vasospasm
and other cerebrovascular pathologies. [9, 10]. Magnetic
resonance angiography (MRA) has been reported to exag-
gerate vascular narrowing [11]. CT-angiography (CTA) has
shown good accuracy to detect vasospasm in the basal vessel
trunks but less sensitivity for peripheral vasospasms [9]. One
major advantage of DSA is the possibility to perform balloon
dilatation and/or pharmacological angioplasty immediately
after the diagnostic procedure. However, the administration
of contrast medium, the invasiveness of the procedure, and
the exposure to radiation prohibit its serial use for diagnostic
purposes. Therefore, routine DSA is not implemented in our
treatment protocol for SAH patients.
It may be discussed what extent of vessel narrowing
should be regarded vasospasm. Many authors define severe
vasospasm as the narrowing of vessel diameter of more than
50% [12, 13]. Many patients who develop delayed cerebral
ischemia (DCI), however, have segmental arterial narrowing
of less than 50% and even patients with no marked arterial
narrowing can develop DCI [14]. Dankbaar et al. found
that 57% of patients with angiographic narrowing of more
than 50% and 37% of patients with arterial narrowing of
25–50% developed DCI [15]. A segmental narrowing of the
vessel diameter of 30% equals a reduction of cross-section to
49% and a decrease of flow volume to 24% according to the
Hagen-Poiseuille equation. This has to be compensated by an
at least twofold increase of flow velocity in order to ascertain
cerebral perfusion at levels above the ischemic thresholds
[2]. Therefore, our definition of angiographic vasospasm as
well as for its endovascular treatment was arterial narrowing
of more than 30% and a decreased circulation time in the
respective part of the cerebral vasculature.
A number of invasive methods like microdialysis and
intracerebral CBF-measurement have been tested for their
value to detect DCV in patients after aneurysmal SAH.
Those procedures bear the risks of placement and long-
term monitoring with intracerebral probes like infection
and probe dislocation. Furthermore, they are only successful
if the probes have been placed into an area if the brain
which will eventually be affected by decreased perfusion.
This cannot be reliably predicted. Therefore, these methods
have a higher risk for false negative findings. It was the
aim of the present study to examine noninvasive diagnostic
measures for their diagnostic accuracy. The choice of the
appropriate target parameter is debatable. Classically, cere-
bral infarction and the appearance of DIND as expressions
of progressive ischemia are used as target parameters to
assess cerebral ischemic events [16]. To use angiographic
findings as the study end point, however, is a therapeutic
approach. Endovascular balloon angioplasty of narrowed
vessel trunks and chemical vasospasmolysis are known
to significantly raise CBF above ischemic values and are,
therefore, prophylactic measures to prevent ischemia and
permanent neurological deficit [4, 17, 18].
Neurological examination has been performed using
a standardized protocol assessing awareness, psychomotor
function, cranial nerves, and motor and sensory function.
Patients that were amenable to this detailed examination
were tested following this protocol at least 3 times a day.
Although the number of patients is small, out results show
that neurological assessment has an outstanding diagnos-
tic accuracy. Of all calculated values, the high-negative-
predictive value is the most important parameter as it
excludes that a patient will not be transferred to adequate
treatment if the diagnostic finding is negative. However, a
protocol as detailed as in the present study is not practicable
in somnolent or comatose patients. In these patients, other
diagnostic procedures have to be employed which can be
performed independently of the state of consciousness. TCD
and PCT are diagnostic tools that are readily available, easy
to performm and noninvasive. TCD can be repeated at any
time, PCT can be obtained subsequent to native CT when
the latter are conducted at regular intervals in comatose SAH
patients to exclude secondary infarction, rebleeding, edema,
and so forth.
Both methods have their limitations and are influenced
by factors other than the narrowing of brain supplying
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blood vessels. TCD evaluates flow velocities in intracranial
vessels. The measurement of TCD in the anterior circulation
depends on the patient’s “ultrasound window”, a part of the
temporal bone which has to be permeable for ultrasound
waves [19, 20]. TCD measurements are strongly examiner-
dependent. To exclude major interobserver variability, TCD
measurements were obtained by a trained medical assistant
in our study. Furthermore, flow velocities not only increase
and decrease with changes of the vessel diameter but
also with changes in cardiac output, blood pressure and
blood viscosity. Therefore, a variety of factors, such as
hyperdynamic therapy can contribute to elevations of flow
velocities. Finally, TCD can detect large vessel spasms but not
peripheral vasospasms.
Color-coded CTP-maps are gathered from serial CT-
slices which are repeated during the infusion of contrast
medium. Typically, they are positioned relatively close to
the skull base an can miss perfusion deficits in more
apical areas of the brain, in territories supplied by smaller
branches of the major vessel trunks. PCT-findings can be
contaminated by infarcted tissue, postoperative contusion,
and intracerebral hemorrhage. The acquisition of PCT maps
is, as well, dependent on the examiner. However, PCT maps
are color-coded and detection of asymmetries or bilateral
defects compared to other vessel territory is rather reliable
and of acceptable interobserver variability [7] Wintermark
et al. proposed a user-friendly visual grading system which
was used in this study [8]. The authors found that the Mean
Transit Time (MTT), a parameter similar to the Time to Peak
obtained in our study had the highest accuracy to predict
angiographic vasospasm [8]. Turowski and coworkers found
that a prolonged MTT correlates with clinical deterioration
and angiographic vasospasm [21]. CBF- and Blood-volume-
maps had lower accuracy to predict angiographic vasospasm.
In the present analysis, we found that TTP maps had a
higher sensitivity and a higher NPV than TCD to predict
angiographic vasospasm. Blood volume and CBF-analysis,
however, seem to be of less importance. Except for 2 cases,
Blood Volume and CBF maps only showed pathological
findings when infarction was already demarcated in plain
CT-scans. The combined analysis of TCD and TTP maps
increases specificity, however, at the expense of a lower NPV.
The present analysis can only show a trend and com-
pares different noninvasive methods to predict angiographic
vasospasm which might be treated by balloon angioplasty
or chemical vasospasmolysis. The indication for angiography
did not follow a strict algorithm. Clinical deterioration that
did not timely resolve upon enforced hyperdynamic therapy
contributed to the decision as well as high elevations or
sudden increases of flow velocities in TCD and pathological
findings in PCT. Inmany cases, both TCD- and TTP-findings
were pathological at the same time. Therefore, there will be
a rather large number of undiagnosed cases, in particular
concerning patients with negative clinical, TCD-, or PCT-
findings and the number of true negative findings is likely
to be highly underestimated. Above all, this will result in
an incorrectly low specificity. Regarding specificity, therefore,
the present study, does not claim to supply valid absolute
values. In a previous study evaluating the prognostic value
of TCD and PCT to predict delayed cerebral infarction [7],
both diagnostic methods showed a sensitivity comparable to
the results presented here but amuch higher specificity (TCD
0.5, TTP 0.67). In contrast to the present series, the primary
end point of that study was delayed infarction on native CT-
scans which were obtained at regular intervals and, thus, sup-
ply valid information about the eventual outcome of negative
diagnostic findings. Absolutely reliable prognostic values to
predict angiographic vasospasm could only be determined
if each clinical examination, TCD- and PCT-examination—
positive or negative—was followed by angiography, which is
neither practicable nor responsible.
5. Conclusion
The present data shows a superior diagnostic value of
detailed neurological evaluation. Neurological assessability
should, therefore, be maintained if ever possible and quickly
reestablished after procedures for which patients need anes-
thesia, for example, endovascular and operative procedures.
If patients are comatose and not amenable to a reliable neu-
rological evaluation or have to be kept under analgosedation
due to elevated intracranial pressure, technical tools have
to be used to diagnose cerebral vasospasm. In these cases,
repeatedly obtained PCT is a valuable screening tool to
detect vasospasm and to decide whether a patient should be
forwarded to angiography.
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